Halozyme Therapeutics wants to take over Evotec. The US biopharmaceutical company based in San Diego is offering €2 billion for the German drug developer.
Ambiopharm, a US-based pharmaceutical services company specializing in peptide manufacturing, recently announced the groundbreaking of a 70,000-square-foot (6,504 m2)...
December 10 –12, 2024 | This multi-day event will explore the latest trends and research in the field, including advancements in automation, emphasis on modular and...
US drugmaker Merck & Co. (MSD) has entered into a global license agreement to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific...
Foodgrade phosphoric acid is currently a new product from the Elixir Group that is in demand in Europe and beyond. The Serbian group of companies has commenced production...
BioNTech and Biotheus recently announced the signing of a definitive agreement for the acquisition of Biotheus, a clinical-stage biotechnology company dedicated to the...
Anglo-Swedish drugmaker AstraZeneca plans to invest $3.5 billion in the US to expand the company’s research and manufacturing footprint by the end of 2026.
Dinamiqs, a company specializing in the development and production of viral vectors and part of the Swiss Siegfried Group since May 2023, has inaugurated its new research...
BASF announced plans to invest in additional production capacity for its X3D technology, a new additive manufacturing technology for catalysts based on 3D printing. The...
